These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31623569)

  • 21. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
    Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
    BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
    Alipanah N; Jarlsberg L; Miller C; Linh NN; Falzon D; Jaramillo E; Nahid P
    PLoS Med; 2018 Jul; 15(7):e1002595. PubMed ID: 29969463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editor's Choice - Association Between Metformin Prescription and Abdominal Aortic Aneurysm Growth and Clinical Events: a Systematic Review and Meta-Analysis.
    Thanigaimani S; Singh TP; Unosson J; Phie J; Moxon J; Wanhainen A; Golledge J
    Eur J Vasc Endovasc Surg; 2021 Nov; 62(5):747-756. PubMed ID: 34556425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
    Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis.
    Khattak M; Rehman AU; Muqaddas T; Hussain R; Rasool MF; Saleem Z; Almalki MS; Alturkistani SA; Firash SZ; Alzahrani OM; Bahauddin AA; Abuhussain SA; Najjar MF; Elsabaa HMA; Haseeb A
    Ann Med; 2024 Dec; 56(1):2313683. PubMed ID: 38346381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.
    Griffin SJ; Leaver JK; Irving GJ
    Diabetologia; 2017 Sep; 60(9):1620-1629. PubMed ID: 28770324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.
    Ipsen EØ; Madsen KS; Chi Y; Pedersen-Bjergaard U; Richter B; Metzendorf MI; Hemmingsen B
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013516. PubMed ID: 33210751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis.
    Xu G; Hu X; Lian Y; Li X
    BMC Infect Dis; 2023 Nov; 23(1):813. PubMed ID: 37986146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
    Yang WT; Yang HJ; Zhou JG; Liu JL
    Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment.
    Kumar NP; Moideen K; Viswanathan V; Shruthi BS; Sivakumar S; Menon PA; Kornfeld H; Babu S
    BMC Infect Dis; 2018 Jul; 18(1):345. PubMed ID: 30045688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.
    Dooley KE; Tang T; Golub JE; Dorman SE; Cronin W
    Am J Trop Med Hyg; 2009 Apr; 80(4):634-9. PubMed ID: 19346391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.
    Palmer SC; Mavridis D; Nicolucci A; Johnson DW; Tonelli M; Craig JC; Maggo J; Gray V; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque L; Lloyd A; Ahmad N; Liu Y; Tiv S; Wiebe N; Strippoli GF
    JAMA; 2016 Jul; 316(3):313-24. PubMed ID: 27434443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
    Wang Q; Shi M
    Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus.
    Li T; Providencia R; Mu N; Yin Y; Chen M; Wang Y; Liu M; Yu L; Gu C; Ma H
    Cardiovasc Diabetol; 2021 Jan; 20(1):30. PubMed ID: 33516224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.
    Eshetie S; Gizachew M; Alebel A; van Soolingen D
    PLoS One; 2018; 13(3):e0194675. PubMed ID: 29554144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
    Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes with metformin use in diabetic patients with compensated cirrhosis: a systematic review and meta-analysis.
    Peppas S; Doumas S; Suvarnakar A; Chou J; Arafat A; Ahmad AI; Lewis JH
    Eur J Gastroenterol Hepatol; 2024 May; 36(5):674-682. PubMed ID: 38477839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.